148 related articles for article (PubMed ID: 12369170)
1. [Hyperforin in St. John's wort--drug, extraction and preparations].
Lang F; Biber A; Erdelmeier C
Pharm Unserer Zeit; 2002; 31(5):512-4. PubMed ID: 12369170
[No Abstract] [Full Text] [Related]
2. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
Rückert U; Likussar W; Michelitsch A
Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
[TBL] [Abstract][Full Text] [Related]
3. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
4. Comparison of German St. John's wort products according to hyperforin and total hypericin content.
Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M
J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982
[TBL] [Abstract][Full Text] [Related]
5. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
6. Hyperforin analogues from St. John's wort (Hypericum perforatum).
Verotta L; Appendino G; Jakupovic J; Bombardelli E
J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
[TBL] [Abstract][Full Text] [Related]
7. Determining hyperforin and hypericin content in eight brands of St. John's wort.
de los Reyes GC; Koda RT
Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
[No Abstract] [Full Text] [Related]
8. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
[TBL] [Abstract][Full Text] [Related]
9. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
Fourneron JD; Naït-Si Y
Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
[TBL] [Abstract][Full Text] [Related]
10. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
[TBL] [Abstract][Full Text] [Related]
11. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
[TBL] [Abstract][Full Text] [Related]
12. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
[TBL] [Abstract][Full Text] [Related]
13. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort.
Kuo CH; Chou YC; Liao KC; Shieh CJ; Deng TS
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948004
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
Hokkanen J; Tolonen A; Mattila S; Turpeinen M
Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
[TBL] [Abstract][Full Text] [Related]
17. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
de los Reyes GC; Koda RT
J Pharm Biomed Anal; 2001 Dec; 26(5-6):959-65. PubMed ID: 11600308
[TBL] [Abstract][Full Text] [Related]
18. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
19. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]